Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Asia Pacific Vascular Graft Market would witness market growth of 8.9% CAGR during the forecast period (2018 - 2024). A vascular graft is a medical device which is used as an artificial blood vessel. These devices are implanted into patients suffering from blocked blood vessels. They are used to redirect flow of blood from one area to another. This restores normal flow of blood within the body.
Increasing rate of high blood sugar, vascular disorders, obesity, hypertension, and other risk factors causing blockage in the blood vessels blockage are the key factors influencing the growth of vascular Graft market. Growing elderly population, technological developments, and lifestyle changes (consumption of junk food, tobacco, and alcohol) are other significant factors that are expected to drive the market growth over the forecast period.
On the basis of product, the market report segments the market into Endovascular Aneurysm Repair Stent Grafts, Hemodialysis Access Graft, Peripheral vascular graft, and Coronary Artery By-pass graft. Endovascular Aneurysm Repair Stent Graft are further segmented into Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA). Abdominal Aortic Aneurysm (AAA) is further sub-segmented into Complex and Traditional (AAA).
Raw material is categorized into Polytetrafluoroethylene (PTFE), Biosynthetic, Polyester, and Polyurethane (PU). The end users covered under the report are Hospitals and Ambulatory Surgical Centers. By application, the market is divided into Cardiovascular Diseases, Aneurysm, Kidney failure, Vascular Occlusion, and other Applications. Additionally, cardiovascular disease is further bifurcated into Coronary Artery Disease, Cardiac Aneurysm, Hypertension, and Cardiac Stroke. Based on Country, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia and rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Cardinal Health, Medtronic Plc, Vingmed Danmark A/S, Cook Medical, Lemaitre Vascular, Inc., Terumo Medical Corporation, Endologix, Inc., W. L. Gore & Associates, Inc., and Getinge AB.